ESCALATE: Ending Stigma through Collaboration and Lifting All to Empowerment

Purpose

ESCALATE (Ending Stigma through Collaboration And Lifting All To Empowerment) is a first-of-its kind training and capacity-building initiative specifically designed to address HIV-related stigma that creates barriers at multiple levels of the HIV care continuum.

NMAC created ESCALATE to reflect its mission and relationship to the communities of people with HIV. NMAC “leads with race” as the burdens of the HIV/AIDS epidemic are most deeply felt in racial and ethnic minority communities. HIV stigma reflects these structural inequities and amplifies the multiple stigmas experienced by communities impacted by HIV based on their race, ethnicity, sexual orientation, gender identity, social status, mental health and substance use, and relationship to sex work or incarceration. Only by viewing HIV stigma through these multiple lenses can we address its deep and insidious impacts.

To meet the goals of ESCALATE, NMAC has partnered with Abt Associates (Abt), TRX Development Solutions (TRX), and NORC at the University of Chicago (NORC).

Apply for Training and Technical Assistance

The Challenge

ESCALATE works across multiple levels of the Ending the HIV Epidemic in the U.S. (EHE) initiative and the HIV National Strategic Plan (HIV Plan) to address internalized and externalized HIV-related stigma. Support is provided to agencies funded by the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau's (HAB) Ryan White HIV/AIDS Program (RWHAP).

Pillars of the EHE Initiative

HIV Plan 2021 Goals

ESCALATE Activities

Prevent/
Diagnose

Goal 1: Prevent New HIV Infections

ESCALATE activities indirectly enhance existing prevention efforts. RWHAP providers and systems that are aware of the impact of HIV-related stigma and are trained in stigma-reduction strategies will be better equipped to have conversations with individuals and communities about harm reduction strategies, destigmatize testing and diagnosis, and more consistently prescribe pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). 

Treat

Goal 2: Improve HIV-Related Health Outcomes of People with HIV

ESCALATE Training infuses the RWHAP system with approximately 1,200 individuals trained in stigma-reduction practices to proactively eliminate stigma at RWHAP agencies. 

Treat

Goal 3: Reduce HIV-Related Disparities and Health Inequities 

ESCALATE Technical Assistance (TA) builds support for organizational embrace of practices that reduce HIV stigma and other intersectional forms of stigma experienced by the communities that are most deeply impacted by the HIV epidemic. Because HIV stigma is deeply associated with barriers to diagnosis, engagement, and retention in care, reducing its impact should, in the long-term, reduce demographic and other disparities across the HIV continuum of care. TA will reach up to 150 RWHAP agencies, creating a critical threshold of RWHAP professionals, providers, and community members engaging in stigma reduction and providing models for other agencies to do so.

Treat

Goal 4: Achieve Integrated, Coordinated Efforts that Address the HIV Epidemic among All Partners and Stakeholders

ESCALATE Learning Collaboratives (LCs) bring together RWHAP agencies from across the program parts to build practices and supports for cultural responsiveness and humility that can be disseminated throughout the RWHAP system.

Respond

 

ESCALATE activities will not directly impact this pillar.

Focus Population

ESCALATE is open to all Ryan White HIV/AIDS Program Recipients (Parts A, B, C, & D). This includes community-based organizations, federally qualified health centers, health departments, planning councils, and planning bodies. Recipients interested in applying can do so as Stigma Reduction Teams.

Stigma Reduction Teams will represent a collaboration between community and organization, and consist of 1 person with HIV and at least 1 RWHAP partner. A Stigma Reduction Team may have multiple RWHAP partners, but must always have 1 person with HIV as a partner.

Through participation in training, TA, and LCs, Stigma Reduction Teams will support people with HIV in urban, rural, and native communities; Ryan White Care Providers, Planning Councils, in urban, rural, and Native communities, with a special focus on transgender/gender non-conforming individuals, men who have sex with men, and the Black/African-American community.

The Model

ESCALATE provides a three-component program to mitigate and eliminate stigma in HIV-related service provision in the United States. Who can participate?

ESCALATE is open to all Ryan White HIV/AIDS Program Recipients (Parts A, B, C, & D). This includes community-based organizations, federally qualified health centers, health departments, planning councils, and planning bodies.

While ESCALATE will have a strong focus on recruiting participants from within the 57 jurisdictions identified in the Federal Plan to End the HIV Epidemic in the United States, ESCALATE is open to all Ryan White HIV/AIDS Program recipients regardless of jurisdiction.

  • New and Innovative Training: Training is designed to reduce HIV-related stigma through evidence-informed interventions and strategies with an emphasis on cultural humility for HIV service systems, organizations, and individuals. Training is designed to meet the needs of individual RWHAP care providers (e.g., clinicians, administrators, patient navigators) who acknowledge the impact of HIV-related stigma on their client populations and communities. These individuals are ready to create change but may not have the organizational capacity needed to create change across their clinical setting.

    Learn More and Apply for ESCALATE Training (Applications Due July 9th, 2021)

  • Technical Assistance (TA):  ESCALATE will provide tailored TA to individual organizations by assessing TA needs, aligning TA activities and learning opportunities to those needs, and assessing the impact of TA on organizational behavior and change. TA participants will be matched with TA Coaches and Subject Matter Experts to address organization-specific goals through intensive 1:1 TA.

    Learn more and apply for ESCALATE Technical Assistance (Applications Due September 3, 2021)

  • Learning Collaboratives (LC):  ESCALATE will implement two LCs with RWHAP recipients/sub-recipients to address  HIV stigma experienced by their staff and clients. The first LC (LC1) will run from October 2021 to November 2022 with up to eight (8) organizations implementing stigma-reduction initiatives. LC1 members will participate in a multi-session, facilitated Learning Collaborative focused on stigma and cultural humility. LC1 members will have the opportunity to test adaptations to evidence-based stigma-reduction strategies, tools, and practices as well as learn from subject matter experts and peers implementing similar stigma-reduction initiatives with similar populations of focus.

    Learn more and apply for the ESCALATE Learning Collaborative (Applications Due September 3, 2021)

Team

  • NMAC: Training
  • Abt Associates: Technical Assistance
  • NORC at the University of Chicago: Learning Collaborative
  • TRX Development Solutions: Project Evaluation

ESCALATE is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) and the Minority HIV/AIDS Fund as part of a financial assistance award totaling $1,600,906.100 percentage funded by HRSA/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA/HHS, or the U.S. Government.

Contact Information

Project Contacts:

Paul Kawata
Co-PI, NMAC
NMAC
Alexis Marbach, MPH, PMP
Co-PI, Abt Associates
Abt Associates
Charles Shazor
Project Manager
NMAC
Niki Reddy
Project Manager, Abt Associates
Abt Associates

HRSA Contacts:

PO Name
LaQuanta P. Smalley, MPH, BSN, RN, CPN
PO Title
Nurse Consultant – Clinical & Quality Branch
PO Phone
(301) 443-0995

Funding:

Funding Mechanism: Cooperative Agreement

Recipient Organization: NMAC

Grant number: U69HA39335

Project Period: 9/1/2020 - 8/31/2024